Showing posts with label Pfizer. Show all posts
Showing posts with label Pfizer. Show all posts

Monday, May 16, 2016

Pfizer to Acquire Anacor Pharmaceuticals for $5.2 Billion

Pfizer to Acquire Anacor Pharmaceuticals for .2 Billion


After terminating deals with AstraZeneca and most recently, Allergan, Pfizer has turned to relatively smaller biotech companies for acquisitions.


Read More…

Saturday, May 14, 2016

The Pfizer decision and America"s death penalty dilemma

The Pfizer decision and America’s death penalty dilemma





Read More…

Saturday, April 9, 2016

Op-Ed Contributor: Free Pfizer! Why Inversions Are Good for the U.S.

Op-Ed Contributor: Free Pfizer! Why Inversions Are Good for the U.S.


The new Obama administration rules will ultimately discourage companies from investing in the U.S.


Read More…

Wednesday, April 6, 2016

Pfizer and Allergan Are Said to End Merger as Tax Rules Tighten

Pfizer and Allergan Are Said to End Merger as Tax Rules Tighten


The broader reach of regulations, intended to keep companies from cutting deals to move income overseas, appears to have caught many by surprise.










Read More…

Monday, November 23, 2015

Pfizer to Merge With Allergan in $160 Billion Deal

Pfizer to Merge With Allergan in 0 Billion Deal


The agreement would be the latest, and largest, aimed at helping an American company lower its taxes by reincorporating overseas, a tactic known as corporate inversion.


Read More…

Pfizer to Merge With Allergan in $160 Billion Deal

Pfizer to Merge With Allergan in 0 Billion Deal


The agreement would be the latest, and largest, aimed at helping an American company lower its taxes by reincorporating overseas, a tactic known as corporate inversion.










Read More…

News: Morning Agenda: Pfizer and Allergan Reach $150 Billion Deal

News: Morning Agenda: Pfizer and Allergan Reach 0 Billion Deal


Puerto Rico’s Creditors Open to Debt Exchange | Petco Close to $ 4.7 Billion Sale to CVC and Canadian Pension Fund


Read More…

Pfizer and Allergan Reach $150 Billion Merger Deal

Pfizer and Allergan Reach 0 Billion Merger Deal


The deal, to be announced Monday, would create a huge new pharmaceutical giant and could potentially help Pfizer lower its American tax rate.










Read More…

Sunday, November 22, 2015

Pfizer and Allergan Near $150 Billion Merger Deal

Pfizer and Allergan Near 0 Billion Merger Deal


A deal would create a huge new pharmaceutical giant and could potentially help Pfizer lower its American tax rate.










Read More…

Pfizer and Allergan Near $150 Billion Merger Deal

Pfizer and Allergan Near 0 Billion Merger Deal


A deal would create a huge new pharmaceutical giant and could potentially help Pfizer lower its American tax rate.


Read More…

Saturday, November 14, 2015

Strategies: A Tax-Cutting Move That Pfizer Can Hardly Resist

Strategies: A Tax-Cutting Move That Pfizer Can Hardly Resist


The drug maker’s latest move toward shifting its legal tax headquarters abroad has drawn scorn from politicians, but it’s a shareholder-friendly tactic.










Read More…

Strategies: A Tax-Cutting Move That Pfizer Can Hardly Resist

Strategies: A Tax-Cutting Move That Pfizer Can Hardly Resist


The drug maker’s latest move toward shifting its legal tax headquarters abroad has drawn scorn from politicians, but it’s a shareholder-friendly tactic.


Read More…